Your browser doesn't support javascript.
loading
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kosiborod, Mikhail N; Esterline, Russell; Furtado, Remo H M; Oscarsson, Jan; Gasparyan, Samvel B; Koch, Gary G; Martinez, Felipe; Mukhtar, Omar; Verma, Subodh; Chopra, Vijay; Buenconsejo, Joan; Langkilde, Anna Maria; Ambery, Philip; Tang, Fengming; Gosch, Kensey; Windsor, Sheryl L; Akin, Emily E; Soares, Ronaldo V P; Moia, Diogo D F; Aboudara, Matthew; Hoffmann Filho, Conrado Roberto; Feitosa, Audes D M; Fonseca, Alberto; Garla, Vishnu; Gordon, Robert A; Javaheri, Ali; Jaeger, Cristiano P; Leaes, Paulo E; Nassif, Michael; Pursley, Michael; Silveira, Fabio Serra; Barroso, Weimar Kunz Sebba; Lazcano Soto, José Roberto; Nigro Maia, Lilia; Berwanger, Otavio.
Afiliación
  • Kosiborod MN; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA; School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia. Electronic address: mkosiborod@saint-lukes.org.
  • Esterline R; Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Furtado RHM; Academic Research Organization-Hospital Israelita Albert Einstein, Sao Paulo, Brazil; Instituto do Coracao do Hospital das Clinicas da FMUSP, Sao Paulo, Brazil.
  • Oscarsson J; Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Gasparyan SB; Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Koch GG; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Martinez F; National University of Córdoba, Córdoba, Argentina.
  • Mukhtar O; Experimental Medicine and Immunotherapeutics Division, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Verma S; Division of Cardiac Surgery, Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, ON, Canada; Department of Surgery and Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
  • Chopra V; Max Super Speciality Hospital, New Delhi, India.
  • Buenconsejo J; Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Langkilde AM; Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Ambery P; Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Tang F; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.
  • Gosch K; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.
  • Windsor SL; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.
  • Akin EE; George Clinical Inc, Overland Park, KS, USA.
  • Soares RVP; Academic Research Organization-Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
  • Moia DDF; Academic Research Organization-Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
  • Aboudara M; Division of Pulmonary and Critical Care, Saint Luke's Health System, Kansas City, MO, USA.
  • Hoffmann Filho CR; Hospital Regional Hans Dieter Schmidt, Joinville, Brazil.
  • Feitosa ADM; PROCAPE, Recife, Brazil.
  • Fonseca A; Hospital Coracao do Brasil, Brasília, Brazil.
  • Garla V; Department of Endocrinology, Diabetes and Metabolism, Internal Medicine, University of Mississippi Medical Center, Jackson, MS, USA; Mississippi Center for Clinical and Translational Research, Jackson, MI, USA.
  • Gordon RA; North Shore University Health System, Evanston, IL, USA.
  • Javaheri A; Washington University School of Medicine, St Louis, MO, USA.
  • Jaeger CP; Hospital Mãe de Deus, Porto Alegre, Brazil.
  • Leaes PE; Irmandade Da Santa Casa de Misericórdia de Porto Alegre, Brazil.
  • Nassif M; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.
  • Pursley M; Heart Group of the Eastern Shore, Fairhope, AL, USA.
  • Silveira FS; Centro de Pesquisa Clínica do Coração, Aracaju, Brazil.
  • Barroso WKS; Liga de Hipertensão Arterial -Universidade Federal de Goiás, Brazil; HCAMP-Secretaria Estadual de Saúde, Goiás, Brazil.
  • Lazcano Soto JR; Instituto de Investigaciones Aplicadas a la Neurociencia AC, Durango City, Mexico.
  • Nigro Maia L; Centro Integrado de Pesquisas, Hospital de Base, São José do Rio Preto, Brazil.
  • Berwanger O; Academic Research Organization-Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Lancet Diabetes Endocrinol ; 9(9): 586-594, 2021 09.
Article en En | MEDLINE | ID: mdl-34302745
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases / 6_sense_organ_diseases Asunto principal: Compuestos de Bencidrilo / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Factores de Riesgo Cardiometabólico / COVID-19 / Glucósidos / Insuficiencia Multiorgánica Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Diabetes Endocrinol Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases / 6_sense_organ_diseases Asunto principal: Compuestos de Bencidrilo / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Factores de Riesgo Cardiometabólico / COVID-19 / Glucósidos / Insuficiencia Multiorgánica Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Diabetes Endocrinol Año: 2021 Tipo del documento: Article